Screening for diabetic retinopathy
Screening is worthwhile when certain criteria are met: a disease has public health importance; an effective treatment exists; an interval exists within which treatment can effect benefit; and the disease is neither too rare nor too common.1 Screening for diabetes mellitus in those over 40 years of age and screening for diabetic retinopathy (DR) in those with known diabetes mellitus fulfill these criteria.2,3 Beyond improving health-related outcomes, treatment of diabetes and DR is cost effective.4,5,6 Thus, the value of screening for DR is widely recognized. There is, however, controversy regarding the best screening method and screening intervals. 7 © 2010 Springer-Verlag New York.
- Diabetic Retinopathy: Evidence-Based Management
Start / End Page
International Standard Book Number 13 (ISBN-13)
Digital Object Identifier (DOI)